BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36304121)

  • 1. Efficient antigen delivery by dendritic cell-targeting peptide via nucleolin confers superior vaccine effects in mice.
    Matsuda T; Misato K; Tamiya S; Akeda Y; Nakase I; Kuroda E; Takahama S; Nonaka M; Yamamoto T; Fukuda MN; Yoshioka Y
    iScience; 2022 Nov; 25(11):105324. PubMed ID: 36304121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-CD40 Antibody Fused to CD40 Ligand Is a Superagonist Platform for Adjuvant Intrinsic DC-Targeting Vaccines.
    Ceglia V; Zurawski S; Montes M; Kroll M; Bouteau A; Wang Z; Ellis J; Igyártó BZ; Lévy Y; Zurawski G
    Front Immunol; 2021; 12():786144. PubMed ID: 35095862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral Delivery of Probiotics Expressing Dendritic Cell-Targeting Peptide Fused with Porcine Epidemic Diarrhea Virus COE Antigen: A Promising Vaccine Strategy against PEDV.
    Wang X; Wang L; Huang X; Ma S; Yu M; Shi W; Qiao X; Tang L; Xu Y; Li Y
    Viruses; 2017 Oct; 9(11):. PubMed ID: 29068402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced effects of DNA vaccine against botulinum neurotoxin serotype A by targeting antigen to dendritic cells.
    Chen BY; Zhou G; Li QL; Lu JS; Shi DY; Pang XB; Zhou XW; Yu YZ; Huang PT
    Immunol Lett; 2017 Oct; 190():118-124. PubMed ID: 28802641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Delivery of Nanovaccine to Dendritic Cells via DC-Binding Peptides Induces Potent Antiviral Immunity in vivo.
    Lu Y; Liu ZH; Li YX; Xu HL; Fang WH; He F
    Int J Nanomedicine; 2022; 17():1593-1608. PubMed ID: 35411142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo targeting of antigens to human dendritic cells through DC-SIGN elicits stimulatory immune responses and inhibits tumor growth in grafted mouse models.
    Kretz-Rommel A; Qin F; Dakappagari N; Torensma R; Faas S; Wu D; Bowdish KS
    J Immunother; 2007 Oct; 30(7):715-26. PubMed ID: 17893564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An allergen-fused dendritic cell-binding peptide enhances in vitro proliferation of equine T-cells and cytokine production.
    Ziegler A; Olzhausen J; Hamza E; Stojiljkovic A; Stoffel MH; Garbani M; Rhyner C; Marti E
    Vet Immunol Immunopathol; 2022 Jan; 243():110351. PubMed ID: 34800874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusion of Bacterial Flagellin to a Dendritic Cell-Targeting αCD40 Antibody Construct Coupled With Viral or Leukemia-Specific Antigens Enhances Dendritic Cell Maturation and Activates Peptide-Responsive T Cells.
    Schmitt S; Tahk S; Lohner A; Hänel G; Maiser A; Hauke M; Patel L; Rothe M; Josenhans C; Leonhardt H; Griffioen M; Deiser K; Fenn NC; Hopfner KP; Subklewe M
    Front Immunol; 2020; 11():602802. PubMed ID: 33281829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of antigen to porcine dendritic cells by fusing antigen with porcine dendritic cells targeting peptide.
    Xia T; Wang N; Tang Y; Gao Y; Gao C; Hao J; Jiang Y; Wang X; Shan Z; Li J; Zhou H; Cui W; Qiao X; Tang L; Wang L; Li Y
    Front Immunol; 2022; 13():926279. PubMed ID: 36159835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune Adjuvant Targeting Micelles Allow Efficient Dendritic Cell Migration to Lymph Nodes for Enhanced Cellular Immunity.
    Yang X; Lian K; Meng T; Liu X; Miao J; Tan Y; Yuan H; Hu F
    ACS Appl Mater Interfaces; 2018 Oct; 10(39):33532-33544. PubMed ID: 30192498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cell-targeted recombinantLactobacilli induce DC activation and elicit specific immune responses against G57 genotype of avian H9N2 influenza virus infection.
    Sun Y; Qian J; Xu X; Tang Y; Xu W; Yang W; Jiang Y; Yang G; Ding Z; Cong Y; Wang C
    Vet Microbiol; 2018 Sep; 223():9-20. PubMed ID: 30173758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening and Identification of a Chicken Dendritic Cell Binding Peptide by Using a Phage Display Library.
    Ma S; Qiao X; Xu Y; Wang L; Zhou H; Jiang Y; Cui W; Huang X; Wang X; Tang L; Li Y
    Front Immunol; 2019; 10():1853. PubMed ID: 31447851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The STING activator c-di-AMP exerts superior adjuvant properties than the formulation poly(I:C)/CpG after subcutaneous vaccination with soluble protein antigen or DEC-205-mediated antigen targeting to dendritic cells.
    Volckmar J; Knop L; Stegemann-Koniszewski S; Schulze K; Ebensen T; Guzmán CA; Bruder D
    Vaccine; 2019 Aug; 37(35):4963-4974. PubMed ID: 31320219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted delivery of vaccine to dendritic cells by chitosan nanoparticles conjugated with a targeting peptide ligand selected by phage display technique.
    Jung SN; Kang SK; Yeo GH; Li HY; Jiang T; Nah JW; Bok JD; Cho CS; Choi YJ
    Macromol Biosci; 2015 Mar; 15(3):395-404. PubMed ID: 25393207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-Linked Peptide Nanoclusters for Delivery of Oncofetal Antigen as a Cancer Vaccine.
    Tsoras AN; Champion JA
    Bioconjug Chem; 2018 Mar; 29(3):776-785. PubMed ID: 29436221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel peptide carrier for efficient targeting of antigens and nucleic acids to dendritic cells.
    Sioud M; Skorstad G; Mobergslien A; Sæbøe-Larssen S
    FASEB J; 2013 Aug; 27(8):3272-83. PubMed ID: 23671272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fc receptor-targeting of immunogen as a strategy for enhanced antigen loading, vaccination, and protection using intranasally administered antigen-pulsed dendritic cells.
    Pham GH; Iglesias BV; Gosselin EJ
    Vaccine; 2014 Sep; 32(40):5212-20. PubMed ID: 25068496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8
    Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y
    Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two different PEGylation strategies for the liposomal adjuvant CAF09: Towards induction of CTL responses upon subcutaneous vaccine administration.
    Schmidt ST; Olsen CL; Franzyk H; Wørzner K; Korsholm KS; Rades T; Andersen P; Foged C; Christensen D
    Eur J Pharm Biopharm; 2019 Jul; 140():29-39. PubMed ID: 31055066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cells transduced with tumor-associated antigen gene elicit potent therapeutic antitumor immunity: comparison with immunodominant peptide-pulsed DCs.
    Nakamura M; Iwahashi M; Nakamori M; Ueda K; Ojima T; Naka T; Ishida K; Yamaue H
    Oncology; 2005; 68(2-3):163-70. PubMed ID: 16006753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.